Investors are increasingly eyeing the fast-growing MedSurg equipment space, which is projected to witness a compound annual growth rate (CAGR) of 9.54% from 2025 to 2030 (per Grand View Research). Two ...

Lumen-apposing metal stents (LAMS) have been recently developed to improve treatment outcomes in the endoscopic management of pancreatic fluid collections (PFC), particularly in walled-off necrosis ...

Boston Scientific’s BSX Endoscopy business develops and manufactures devices to diagnose and treat a broad range of gastrointestinal (GI) conditions using innovative, less invasive technologies. The ...

Boston Scientific (BSX) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting ...

Boston Scientific (NYSE:BSX) recently entered into a significant agreement with Bittium Biosignals Ltd. to supply ECG devices, valued between USD 30 to 45 million, which strengthens their cardiac ...

The U.S. Food and Drug Administration said on Monday that it had launched a generative AI tool, Elsa, aimed at improving efficiency across its operations, including scientific reviews.

Scientific Discoveries, and Dreams, in the Balance. Research breakthroughs are often sagas of passion, curiosity and sacrifice. If Trump’s proposed budget cuts for 2026 are enacted, many such ...

Automated programs gathering training data for artificial-intelligence tools are overwhelming academic websites.

What's happening: Pineda's husband, a TPS recipient from El Salvador, was released after two days, but she said the family is still grappling with the aftermath. Neither of them is sleeping well. Jose ...